Look out for the STAMPEDE!

Systemic therapy for metastatic prostate cancer has changed radically in the last 10 years with the introduction of several novel agents that have shown significant improvements in progression free and overall survival. The latest major breakthrough is the introduction of a relatively old drug, docetaxel …

More details... Comments (5)

Bike 2 BAUS 2015

9am on Saturday 13 June and we all met outside BAUS HQ at the Royal college of Surgeons in Lincolns Inn Fields, 14 of us cycling to the BAUS annual conference in Manchester to raise money for The Urology Foundation (TUF). A total of 220 …

More details... Comments (8)

NICE recommend rejecting degarelix for acute metastatic prostate cancer

Your action is required urgently!
 
Most unfortunately, NICE has recently recommended that degarelix should no longer be approved for use in patients presenting acutely with metastatic prostate cancer (a group within its current licensed indication). As a clinician I have often been faced with patients presenting …

More details... Comments (17)

Fixing dad

It’s worrying to hear that one in six people in the UK suffers from type 2 diabetes and even more worrying to know that one in three of us is prediabetic for type 2 diabetes. That means we are all likely to know someone in …

More details... Comment (1)

NHS crisis: time to move away from ‘free at the point of use’?

The NHS crisis experienced last winter is not a one-off, but marks the beginning of an extended period when the NHS is likely to be chronically short of finance. It is probable that in the very near future the Treasury will be either unable or …

More details... Comments (20)

Suicide or accidents – which is the biggest killer of our young men?

A key message that is commonly heard with regard to men’s health issues is that suicide is the biggest single killer of young men. Indeed, this was the strap line from the recent Panorama programme on male suicide. However, it is not entirely true and …

More details... Comments (2)

Men’s health: what are the odds?

Over the past 15 years I have often asked at the start of my lectures ‘What do you think are the main health risks facing men?’ If the audience consists of professionals delivering care, or policy makers planning services, or the lay public, it is …

More details... Comments (13)

Taking the lead: success and leadership in medicine

To be a leader, it is important to be perceived as successful. That of course begs the question: how can ‘success’ in medicine’ be defined? Unlike the world of business, where success is largely gauged in financial terms, a successful doctor is arguably one who treats …

More details... Comments (55)

PSA – targeting the men at highest risk

PSA testing – as controversial as ever, with views ranging from ‘every man should know his PSA’ to ‘PSA is a terrible test and men should be strongly discouraged from testing’. In this article, Jon Rees and members of the Education Advisory Team at Prostate …

More details... Comments (5)

NICE draft guidelines on referral for suspected cancer – two steps forward and another step back for bladder cancer

The updated NICE guidelines on referral for suspected cancer have recently been put out for consultation amongst stakeholders (1). Whilst there is no doubt that the original guidelines (2) were a step in the right direction for urological cancers when they came out in 2005, …

More details... Comments (7)

Web design and marketing agency Leamington Spa